Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.21+0.18 (+5.94%)
Close on Nov 13, 2026Market cap $12.68MP/E –Yield –
Onconetix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Onconetix's enterprise value was $8.32M on Nov 11, 2026, against $2.17B a year earlier. Over the last 5 years it ranged from -$5.00M to $90.42B, with a median of $1.76B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.32M | -99.3% |
| 2025 | Dec 31, 2025 | $1.22B | -53.7% |
| 2024 | Dec 31, 2024 | $2.63B | +49.5% |
| 2023 | Dec 29, 2023 | $1.76B | -78.2% |
| 2022 | Dec 30, 2022 | $8.05B | – |
See a number that looks wrong?